Literature DB >> 32391687

Biomimetic Rebuilding of Multifunctional Red Blood Cells: Modular Design Using Functional Components.

Jimin Guo1,2, Jacob Ongudi Agola1, Rita Serda2, Stefan Franco2, Qi Lei3, Lu Wang4, Joshua Minster1, Jonas G Croissant1, Kimberly S Butler5, Wei Zhu3, C Jeffrey Brinker1.   

Abstract

The design and synthesis of artificial materials that mimic the structures, mechanical properties, and ultimately functionalities of biological cells remains a current holy grail of materials science. Here, based on a silica cell bioreplication approach, we report the design and construction of synthetic rebuilt red blood cells (RRBCs) that fully mimic the broad properties of native RBCs: size, biconcave shape, deformability, oxygen-carrying capacity, and long circulation time. Four successive nanoscale processing steps (RBC bioreplication, layer-by-layer polymer deposition, and precision silica etching, followed by RBC ghost membrane vesicle fusion) are employed for RRBC construction. A panel of physicochemical analyses including zeta-potential measurement, fluorescence microscopy, and antibody-mediated agglutination assay proved the recapitulation of RBC shape, size, and membrane structure. Flow-based deformation studies carried out in a microfluidic blood capillary model confirmed the ability of RRBCs to deform and pass through small slits and reconstitute themselves in a manner comparable to native RBCs. Circulation studies of RRBCs conducted ex ovo in a chick embryo and in vivo in a mouse model demonstrated the requirement of both deformability and native cell membrane surface to achieve long-term circulation. To confer additional non-native functionalities to RRBCs, we developed modular procedures with which to load functional cargos such as hemoglobin, drugs, magnetic nanoparticles, and ATP biosensors within the RRBC interior to enable various functions, including oxygen delivery, therapeutic drug delivery, magnetic manipulation, and toxin biosensing and detection. Taken together, RRBCs represent a class of long-circulating RBC-inspired artificial hybrid materials with a broad range of potential applications.

Entities:  

Keywords:  bioapplications; biomimicry; drug carrier; multifunction; red blood cells

Mesh:

Substances:

Year:  2020        PMID: 32391687     DOI: 10.1021/acsnano.9b08714

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  6 in total

1.  Long-term whole blood DNA preservation by cost-efficient cryosilicification.

Authors:  Liang Zhou; Qi Lei; Jimin Guo; Yuanyuan Gao; Jianjun Shi; Hong Yu; Wenxiang Yin; Jiangfan Cao; Botao Xiao; Jacopo Andreo; Romy Ettlinger; C Jeffrey Brinker; Stefan Wuttke; Wei Zhu
Journal:  Nat Commun       Date:  2022-10-21       Impact factor: 17.694

2.  Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation.

Authors:  Chen Wang; Min Wang; Yan Zhang; Hongxin Jia; Binbin Chen
Journal:  J Pharm Anal       Date:  2021-06-12

Review 3.  Biological Cells as Therapeutic Delivery Vehicles.

Authors:  Lucas M Bush; Connor P Healy; Shwan B Javdan; Jonathan C Emmons; Tara L Deans
Journal:  Trends Pharmacol Sci       Date:  2020-12-17       Impact factor: 14.819

Review 4.  State-of-the-art methods for the treatment of severe hemorrhagic trauma: selective aortic arch perfusion and emergency preservation and resuscitation-what is next?

Authors:  Atsuyoshi Iida; Hiromichi Naito; Tsuyoshi Nojima; Tetsuya Yumoto; Taihei Yamada; Noritomo Fujisaki; Atsunori Nakao; Takeshi Mikane
Journal:  Acute Med Surg       Date:  2021-03-26

Review 5.  Nano/Micromotors in Active Matter.

Authors:  Chenglin Lv; Yuguang Yang; Bo Li
Journal:  Micromachines (Basel)       Date:  2022-02-17       Impact factor: 2.891

6.  Biomimetic recombinant of red blood cell membranes for improved photothermal therapy.

Authors:  Pengkai Wu; Xing Jiang; Shuai Yin; Ying Yang; Tianqing Liu; Kaikai Wang
Journal:  J Nanobiotechnology       Date:  2021-07-18       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.